HUMA
Humacyte, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website umacyte.com
- Employees(FY) 164
- ISIN US44486Q1031
Performance
+40.04%
1W
+106.86%
1M
+43.21%
3M
+159.43%
6M
+122.89%
YTD
+52.9%
1Y
Profile
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Investment Analysis Report: HUMA
Overview
HUMA is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $457.8 million. In this report, we will conduct a comprehensive analysis of HUMA's financial health, valuation, earnings and revenue growth, profitability, o...
Technical Analysis of HUMA 2024-05-10
Overview:
In analyzing the technical indicators for HUMA stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming tradi...
Recent News & Updates
- 2024-05-16 02:20
- 2024-05-13 08:00
- 2024-05-12 20:00
- 2024-05-10 14:43
- 2024-05-10 07:00
- 2024-05-09 23:54
HUMA Stock Earnings: Humacyte Misses EPS for Q1 2024(Investorplace)
- 2024-05-09 19:00
- 2024-05-06 08:00
- 2024-05-05 20:00
- 2024-04-20 20:39
10 Stocks American Politicians are Buying in 2024(Insidermonkey)
- 2024-03-26 16:05
- 2024-03-26 04:05
- 2024-03-23 10:16
Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript(Insider Monkey)
- 2024-03-22 22:16
- 2024-03-22 07:00
- 2024-03-21 23:53
HUMA Stock Earnings: Humacyte Meets EPS for Q4 2023(Investorplace)
- 2024-03-21 19:00
- 2024-03-18 20:58
- 2024-03-18 08:00
- 2024-03-17 20:00
- 2024-03-01 09:16
- 2024-02-29 21:18
- 2024-02-29 20:16
- 2024-02-29 16:01
- 2024-02-29 08:18
- 2024-02-29 03:01
- 2024-02-11 20:13
- 2024-02-09 08:00
- 2024-02-08 19:00
- 2023-12-12 08:00
Page 1 of 4
previousnext